CBOE

ARK Genomic Revolution ETF (ARKG)

535 Thanks from members

The ARK Genomic Revolution ETF (ARKG) exhibits a strongly positive net sentiment (over 42% positive versus negative), driven by recent biotech valuation corrections, technical support near $34–$35, and strong institutional inflows despite historical high-beta volatility.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →